Parasternal EV-ICD System Pivotal Study

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, multi-center, single-arm pivotal study to evaluate the safety and effectiveness of the Parasternal EV-ICD System. Up to 280 eligible adults with ICD indications will be enrolled at up to 40 sites worldwide, with at least half in the United States. The primary safety endpoint is freedom from major adverse device effects through six months, while the primary effectiveness endpoint is successful defibrillation during an induced ventricular arrhythmia test in the final system configuration. Participants will receive an Atala lead and EV-ICD Pulse Generator placed on the left chest, with follow-up visits every six months for at least 2.5 years. Endpoints will be summarized in a final report after all active subjects complete the 6-month visit.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. At least 18 years old
2. Class I or IIa indication for implantation of an ICD according to the ACC/AHA/HRS Guidelines or ESC guidelines

Exclusion Criteria:

1. Patients who cannot read or write
2. Expected survival \< 1 year
3. Pregnant or nursing subjects and those who plan pregnancy during the clinical investigation follow-up period
4. Participation in any concurrent clinical study without prior approval from the Sponsor
5. Inability or unwillingness to provide informed consent to participate in the study
6. Any known circumstances which may prevent the completion of protocol testing and data collection through the 6-month follow-up visit
7. Circumstances that may prevent data collection or completion of specified follow-up visits
8. Allergies to any device materials listed in the Instructions for Use (IFU)
9. Contraindication for temporary suspension of oral/systemic anticoagulation
10. Known history of lung disease with FEV1 \< 1.0 Liter

    Device Related:
11. Implanted with or planned implantation of any device which delivers current in the body that may interfere with therapy delivery, including, but not limited to a pacemaker, LVAD or neurostimulator
12. Implanted with a subcutaneous ICD lead, subcutaneous coils/arrays, epicardial patches or epicardial pace/sense leads
13. Any known need for MRI prior to approval of MRI conditional labeling

    Anatomy Related:
14. Known structural abnormalities of the heart that may increase risk of the Parasternal EV-ICD System procedure
15. Known obstructed or restricted pathway into the mediastinum for the Atala™ lead
16. Prior surgery with disruption of the lung, pericardium or connective tissue between the sternum and pericardium, including sternotomy of any type
17. Known significant anatomic derangement of or within the thorax (e.g., pectus excavatum, significant scoliosis)
18. History of thoracic radiation therapy or other medical treatments/conditions which may complicate the Parasternal EV-ICD System implant procedure
19. Known adhesions in the thorax or history of medical treatments, surgeries or conditions that increase the potential for adhesions in the thorax
20. Surgically corrected congenital heart disease (not including catheter-based procedures)

    Cardiac Related:
21. Indication for permanent bradycardia pacing or cardiac resynchronization therapy
22. Decompensated heart failure
23. Currently on inotropic therapy
24. Known history of pericardial disease, pericarditis or mediastinitis
25. Risk factors associated with defibrillation testing:

    * Severe aortic stenosis
    * Current Intracardiac LA or LV thrombus
    * Severe proximal three-vessel or left main coronary artery disease without revascularization
    * Hemodynamic instability
    * Unstable angina
    * Recent stroke or transient ischemic attack (within the last 3 months)
    * Known inadequate external defibrillation
    * LVEF \< 20% (most recent assessment; must be within 180 days of consent)
    * LVEDD \>70 mm (most recent assessment; must be within 180 days of consent)

Where it's running

• St. Bernards Heart and Vascular
  Jonesboro, Arkansas, United States Recruiting
• Mount Sinai Medical Center of Florida
  Miami Beach, Florida, United States Recruiting
• Emory University
  Atlanta, Georgia, United States Recruiting
• Endeavor Health
  Glenview, Illinois, United States Recruiting
• Baptist Health
  Lexington, Kentucky, United States Recruiting
• John Hopkins Medical
  Baltimore, Maryland, United States Recruiting

Study contacts

• Study coordinator: Sarah Hase, BS, CCRA
• Email: sarah@atacor.com
• Phone: +1 949-545-9820

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluating different approaches to cardiac pacing in patients

  This study is testing different ways to place pacemakers in adults to see which methods work best and are safest for patients needing heart support.

  Recruiting at 31 sites University Hospital of Ferrara · Ferrara, FE and 30 other locations · NCT06324682

• Stereotactic body radiation therapy versus catheter ablation for ventricular tachycardia in structural heart disease

  This trial will test whether a focused radiation treatment (SBRT) can reduce ventricular tachycardia episodes more than standard catheter ablation in people with advanced structural heart disease.

  Recruiting Western Sydney Local Health District · Westmead · NCT06360939

• Evaluating dexmedetomidine for treating electrical storm in patients

  This study is testing if a sedative called dexmedetomidine can help adults with electrical storm, which causes dangerous heart rhythms, by reducing these episodes and improving their recovery.

  Recruiting Phase 3 Ottawa Heart Institute Research Corporation · Rochester, Minnesota and 1 other locations · NCT06281977

• Using Stellate Ganglion Block to Treat Arrhythmic Storm

  This study is testing if a special nerve block can help people having a severe heart rhythm problem called arrhythmic storm by reducing the number of shocks they need from a defibrillator.

  Recruiting at 36 sites Fondazione IRCCS Policlinico San Matteo di Pavia · Alessandria, AL and 37 other locations · NCT05720936

• Registry for monitoring heart conditions

  This study is collecting health information from people with heart symptoms to see if it can help doctors catch heart problems earlier and understand them better.

  Recruiting Maastricht University Medical Center · Maastricht, Limburg · NCT04976348

• Registry for implantable cardiac devices

  This study is tracking how well pacemakers and defibrillators work for people with heart rhythm problems to see if they can improve patient care and outcomes.

  Recruiting Heinrich-Heine University, Duesseldorf · Düsseldorf · NCT03360227

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.